University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...

The Vietnamese Ministry of Health has assigned three major hospitals -- K Hospital, Cho Ray Hospital, and Hue Central Hospital -- to develop proton therapy centers for advanced cancer treatment across ...

The center provides highly specialized care to children aged 1 month to 18 years. Four allergists work here, three of whom have the highest qualification category in allergology/immunology; the head ...

As part of their mission to make expert eye care accessible to all, Pediatric Eye Specialists offers a range of payment options, including Medicaid and cash-pay solutions. This commitment to ...

Office Practicum, a leader in pediatric technology solutions, is excited to introduce SocialSavvy, a powerful new tool that helps pediatric practices effortlessly connect with their communities ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...

Between 15% and 20% of U.S. adults over the age of 65 have obstructive sleep apnea (OSA), according to research in the ...

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

The intensive therapy helps children with developmental, neurological or physical challenges to progress their motor skills, ...